Patient-Centered Approach for Treatment Decisions in Mitral Valve Prolapse

Recruiting Observational Study
Mitral Valve Prolapse
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 and older
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Northwell Health · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a qualitative and quantitative study that seeks to obtain information from patients with degenerative mitral valve prolapse and providers regarding factors important in deciding between surgical mitral valve repair (MVR) and transcatheter edge-to-edge repair (TEER). Findings from this study will provide data that can be used to develop decision aids that can assist patients in decision mak…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age 21 years and older * Diagnosis of degenerative mitral valve regurgitation Exclusion Criteria: * Non-English speaking * Unable to consent on own behalf * Previous mitral surgery
Contacts

Nancy Stone, MEd, NBC-HWC

816-932-5367

nanstone@saint-lukes.org

CONTACT

Shangyi Liu, MS

516-757-5949

sliu11@northwell.edu

CONTACT